(Q54367653)

28 May 2018

title

Combined treatment of Parkinson's disease with amantadine and L-dopa. (English)

1 reference

28 May 2018

1 reference

1

G Scotti

1 reference

28 May 2018

language of work or name

English

0 references

publication date

1 June 1970

1 reference

28 May 2018

published in

The Lancet

1 reference

28 May 2018

volume

1

1 reference

28 May 2018

issue

7661

1 reference

28 May 2018

page(s)

1394-1395

1 reference

28 May 2018

THE BRAIN'S RECORD OF AUDITORY AND VISUAL EXPERIENCE. A FINAL SUMMARY AND DISCUSSION

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2870%2991298-5

7 January 2021

Amantadine in the Treatment of Parkinson's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2870%2991298-5

7 January 2021

Controlled trial of amantadine hydrochloride in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2870%2991298-5

7 January 2021

Amantadine in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2870%2991298-5

7 January 2021

Amantadine for Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2870%2991298-5

7 January 2021

[Clinical observations on a new type of primary aseptic meningoencephalitis (epidemic viral meningoencephalitis)]

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2870%2991298-5

7 January 2021

[On poliomyelitis-like paralytic disease after ECHO virus infection]

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2870%2991298-5

7 January 2021

10.1016/S0140-6736(70)91298-5

Identifiers

DOI

1 reference

28 May 2018

PubMed ID

4194144

1 reference

28 May 2018